
Double Bond Pharmaceutical International AB (publ)
Double Bond Pharmaceutical develops drug candidates including SI-053, a treatment in preparation for clinical Phase I trials for glioblastoma.
Diligo presents capital raises from Nordic growth companies. Follow any company in the open. A free account adds the offer, valuation and terms, documents, the members' Q&A and the option to pre-register non-binding interest.
Public offerings are open to everyone to follow. Private placements are presented to Diligo's members, within the limits that apply to each offer. In both, valuation, documents, interest registration and the members' Q&A open once you have an account.
We present companies preparing a raise, with information and documents provided by the companies themselves. Subscribe and we'll tell you when a new campaign opens to members, with timelines and upcoming plans.
Offer terms, valuation, documents and the members' Q&A are shown to registered members only. Membership is free; members must be 18 or over.
Membership is free; members must be 18 or over.
Create a new accountLog inDiligo runs the presentation and the reach, and registers your non-binding interest. Any binding subscription, identity verification and settlement are handled outside Diligo, by the company or a party with the required authorisation.
Diligo builds the presentation, runs the campaign and brings your capital raise to Diligo's members and network in Sweden, Denmark, Norway, Finland and the wider EU. You keep direct contact with your shareholders.
Our goal is to build a central platform for companies, entrepreneurs and members, fostering growth and development across the European Union. Based in Copenhagen, we proudly consider the Øresund region our home and focus market. We do networking.

Kronprinsessegade 46E, 1306 Copenhagen K · +45 60 13 77 86 · +46 (0)730 939 630
info@diligoedge.com